Anticonvulsant compounds and their use

Synthetic cannabinoid compounds with anticonvulsant activity address the inadequacies of current epilepsy treatments by effectively managing seizures, offering a new therapeutic option for treatment-resistant epilepsy.

JP2026517951APending Publication Date: 2026-06-02JAZZ PHARM RES UK LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
JAZZ PHARM RES UK LTD
Filing Date
2024-05-10
Publication Date
2026-06-02

Smart Images

  • Figure 2026517951000001
    Figure 2026517951000001
  • Figure 2026517951000002
    Figure 2026517951000002
  • Figure 2026517951000003
    Figure 2026517951000003
Patent Text Reader

Abstract

The present invention relates to a group of synthetic cannabinoid compounds having structural formula I as defined herein. The present invention also relates to compositions comprising these compounds, methods for preparing these compounds, intermediates useful for the preparation of these compounds, and the pharmaceutical use of these compounds, in particular for the treatment of seizure-related conditions such as epilepsy.
Need to check novelty before this filing date? Find Prior Art